期刊文献+

别嘌呤醇改善高果糖诱导的大鼠胰岛素抵抗的实验研究 被引量:1

Experimental study of allopurinol on insulin resistance in high-fructose rats
原文传递
导出
摘要 目的研究别嘌呤醇对高果糖诱导的胰岛素抵抗性的影响。方法 Wistar雄性大鼠随机分为正常组、模型组和实验组。实验组和模型组,以高果糖饲料喂养同时用别嘌呤醇(25μg·g^(-1))或等量双蒸水灌胃4周。用口服葡萄糖耐量实验法和高胰岛素-正常葡萄糖钳夹法,研究别嘌呤醇对胰岛素敏感性的作用,测定各组空腹血糖、空腹胰岛素水平和血清尿酸水平的变化。结果血清尿酸水平,与正常组的(1.33±0.12)mg·d L^(-1)相比,模型组(1.82±0.10)mg·d L^(-1)明显增高(P<0.05);与模型组相比,实验组(0.90±0.27)mg·d L^(-1)能明显改善由高果糖引起的尿酸浓度的增高(P<0.05)。不同时间段各组之间血糖值无明显差异。模型组的胰岛素敏感性指标(GIR)明显低于正常组(P<0.05),表明出现胰岛素抵抗性;实验组的GIR值明显高于模型组(P<0.05)。结论别嘌呤醇可以提高骨骼肌胰岛素敏感性,明显改善高果糖诱导的胰岛素抵抗性。 Objective To investigate allopurinol( a xanthine oxidase inhibitor) improves insulin resistance of rats fed with high- fructose diet.Methods Male Wistar rats were randomly divided into 3 groups and each group was fed one of the following diets for 4 weeks: standard chow diet( normal group),high- fructose diet( model group),and high-fructose diet plus allopurinol( allopurinol 25 μg·g^-1,test group). Insulin sensitivity index was assessed from the oral glucose tolerance test( OGTT) and the euglycemic clamp studies. Results Serum uric acid and plasma insulin concentrations were significantly decreased with allopurinol treatment. That the serum uric acid of the model group with( 1. 82 ± 0. 10) mg·d L^-1was significantly increased than normal group with( 1. 33 ± 0. 12) mg · d L^-1,and improved by test group with( 0. 90 ± 0. 27) mg·d L^-1. There was no difference in the levels of glucose with OGTT among the 3 groups. The model group produced a marked decrease in insulin sensitivity index( GIR) compared with normal group( P〈0. 05). Allopurinol treated high- fructose fed rats showed a significant increase in GIR,reaching a similar level as that of the normal group( P〈0. 05). Conclusion Allopurinol may improve of insulin resistance in high- fructose induced insulin resistant.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第14期1311-1313,共3页 The Chinese Journal of Clinical Pharmacology
基金 延边大学科技发展计划基金资助项目(602013102) 延边大学2016年大学生创新创业训练计划科研基金资助项目
关键词 别嘌呤醇 高果糖 胰岛素敏感性 高胰岛素-正常葡萄糖钳夹法 allopurinol high-fructose insulin sensitivity index euglycemic clamp
  • 相关文献

参考文献7

  • 1杨婷,路敏,周颖,崔一民.非布司他和别嘌醇治疗痛风有效性和安全性的Meta分析[J].中国临床药理学杂志,2015,31(2):122-126. 被引量:44
  • 2FEIG D I, SOLESKY B, JOHNSON R J. Effect of allopurinol on blood pressure of adole scents with newly diagnosed essential hyper- tension: a randomized trial[J]. JAMA, 2008, 300(8) :924 -932.
  • 3NAKAGAWA T, HU H, ZHARIKOV S, et al. A causal role for uric acid in fructose induced metabolic syndrome[ J]. Am J Physiol Renal Physiol, 2006, 290(3): 625-631.
  • 4LI P, KOIKE T, JIANG H Y, et al. Acute treatment with candesar- tan cilexetil, an angiotensin II type 1 receptor blocker, improves in- sulin sensitivity in high fructose - diet fed rats[ J]. Horm Metab Res, 2012, 44(4) :286 -290.
  • 5JIANG H Y, KOIKE T, LI P, et al. Combined effects of short - term calorie restriction and exercise on insulin action in normal rats [ J ]. Horm Metab Res, 2010,42(13) :950 -954.
  • 6CHOI J W, FORD E S, GAO X, et al. Sugar sweetened soft drinks, diet soft drinks, and serum uric acid level the Third National Health and Nutrition Examination Survey [ J ]. Arthritis Rheum, 2008, 59 (1): 109-116.
  • 7OSHIDA Y, TACHI Y, MORISHITA Y, et al. Nitric oxide decrea- ses insulin resistance induced by high - fructose feeding [ J ]. Horm Metab Res, 2000, 32(9) :339 -342.

二级参考文献10

  • 1Iwao O. A repeated oral administration study of febuxostat (TMX - 67 ), a non - purine - selective inhibitor of xanthine oxidase, in pa-tients with impaired renal function in Japan : pharmacokinetic and pharmacodynamic study [ J]. J Clin Rheumatol, 2011, 17 (4 Suppl. 2) :S27 -S34.
  • 2Higgins JPT, Green S. Cochrane Handbook for systematic reviews of interventions Version 5. 1. 0. The Cochrane Collaboration, 2011 [EB/OL]. http://www, cochranc-handbook, org, 2013-03.
  • 3Becker MA, Schumacher HR, Espinoza LR, et al. The urate - lowering efficacy and safety of febuxostat in the treatment of the hy- peruricemia of gout :The CONFIRMS trial [ J ]. Arthritis Res and T- her, 2010, 12:63.
  • 4Becker MA, Schumacher HR, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J]. New En J Med, 2005, 353:2450 -2461.
  • 5Schumacher JRHR, Becker MA, Wortmann RL, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout :A 28 - week, phase Ⅲ, ran- domized, double - blind, parallel - group trial [ J]. Arthritis Care Res, 2008, 59 : 1540 - 1548.
  • 6Kamatani N, Fujimori S, Hada T, et al. An allopurinol - con- trolled, randomized, double- dummy, double- blind, parallel be- tween - group, comparative study of febuxostat ( TMX - 67 ), a non - purine - selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan:phase 3 clinical study [J]. J Clin Rheumatol, 2011, 17(4 Suppl. 2) :S13 -S18.
  • 7Naoyuki K, Shin F, Toshikazu H, et al. An allopurinol -controlled, muhicenter, randomized, open - label, parallel between - group, comparative study of febuxostat ( TMX - 67), a non - purine - selec- tive inhibitor of xanthine oxidase, in patients with hyperuricemia in- cluding those with gout in Japan : phase 2 exploratory clinical study [J]. J Clin Rheumatol, 2011, 17(4 Suppl. 2) :S44 -S49.
  • 8El -Zawawy H, Mandell BF. Managing gout:how is it different in patients with chronic kidney disease? [ J ]. Cleve Clin J Med, 2010, 77:919 -928.
  • 9Whehon A, Macdonald PA, Chefo S, et al. Preservation of renal function during gout treatment with febuxostat: a quantitative study [J]. Postgrad Med, 2013, 125:106 - 114.
  • 10原发性痛风诊断和治疗指南[J].中华风湿病学杂志,2011,15(6):410-413. 被引量:667

共引文献43

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部